COMMUNIQUÉS West-GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

09/09/2019 - 14:00

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart

09/09/2019 - 14:00

Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO, Sept. 09, 2019 [...]

Synthorx to Present at the 2019 World Congress of Inflammation

09/09/2019 - 14:00

First-of-its-Kind Genetic Alphabet Platform Used to Design Synthorin for Autoimmune Indications SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company [...]

SubioMed to Attend American Orthopedic Foot and Ankle Society Annual Meeting in Chicago

09/09/2019 - 14:00

Largest Meeting of its Kind for Foot and Ankle Orthopedics Featuring World Class Companies Including Wright Medical, Depuy, Zimmer Bionet and Stryker MINNEAPOLIS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“ [...]

TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019

09/09/2019 - 14:00

TYME-88-PANC Phase II study showed patients being treated with SM-88, who achieved at least an 80% reduction in circulating tumor cell burden, demonstrated a 60% decrease in risk of death SM-88 is an oral, [...]

Harvard Bioscience Announces Strategic Action Plan and Financial Targets

09/09/2019 - 14:00

HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key strategic actions and [...]

ORYZON’s Iadademstat Shows Efficacy Signs in Relapsed SCLC

09/09/2019 - 14:00

Preliminary data from CLEPSIDRA Phase II trial presented at WCLC 2019 Case study showing a 86% tumor reduction Additional data will be presented late September at ESMO-2019 MADRID and CAMBRIDGE, Mass., Sept. 09, 2019 ( [...]

InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference

09/09/2019 - 14:00

TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today [...]

Mustang Bio to Present at Scientific Conferences in September 2019

09/09/2019 - 14:00

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

Bhang Inc. Acquires Leading Wellness Beverage Company, Red Ace Organics

09/09/2019 - 14:00

--First Foray in Beverage Space Positions Bhang Firmly in Health and Wellness Market --Red Ace Products Currently Sold at More Than 1,400 Locations Including Whole Foods & Amazon --Bhang Plans to Launch Red Ace- [...]

BiomX Hosting Key Opinion Leader Symposium on Novel Phage Product for Acne Prone Skin

09/09/2019 - 14:00

NESS ZIONA, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced that it will host a Key Opinion Leader (KOL) meeting on a [...]

Atara Biotherapeutics to Present Initial Efficacy and Additional Safety Results from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019

09/09/2019 - 14:00

ATA188 targets Epstein-Barr Virus (EBV)-infected B cells, which we believe play a fundamental role in the pathogenesis of multiple sclerosis Conference call and webcast to discuss results Friday, September 13, 2019, at [...]

Zogenix Completes Acquisition of Modis Therapeutics, Inc.

09/09/2019 - 14:00

Acquisition strengthens Zogenix’s late-stage, rare disease pipeline with the addition of MT1621, a proprietary investigational therapy for Thymidine Kinase 2 deficiency (TK2d) EMERYVILLE, Calif., Sept. 09, 2019 (GLOBE [...]

United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4

09/09/2019 - 14:00

Orphan drug designation is another significant milestone in the ADP-A2M4 program PHILADELPHIA and OXFORDSHIRE, United Kingdom, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T [...]

Paratek Mourns Passing of Co-founder Dr. Stuart Levy

09/09/2019 - 14:00

BOSTON, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) mourns the loss of Stuart Levy, M.D., who passed way last week. Dr. Levy co-founded the company more than two decades ago along [...]

REPEAT - AgraFlora Organics Provides Final Licensing Guidance and Operational Update At 2.2M Sq./Ft. Delta Greenhouse Complex

09/09/2019 - 14:00

VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

New Patent Covering Enlivex’s AllocetraTM Immunotherapy Was Allowed By The Israeli Patent Authority

09/09/2019 - 13:30

Nes-Ziona, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Israeli Patent Authority issued a notice of allowance for a patent [...]

Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients

09/09/2019 - 13:30

Lead drug candidate, PTI-125, significantly decreased key biomarkers of neuroinflammation and neurodegeneration in all study patients (p<.001) Clinical data support initiation of a Phase 2b study in Alzheimer’s in Q3 [...]

The Russian 10.000 PHA tons per year production plant, led by TAIF Group, enters in the implementation phase

09/09/2019 - 09:31

MOSCOW, BOLOGNA, SEPTEMBER 9 th , 2019 – - The TAIF JSC Group, a player in the traditional petrochemical sector, announced the start of the operational phase of the 10,000-tonnes per year PHA project to be implemented [...]